The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer.
Kasajima M, Igawa S, Manaka H, Yamada K, Akazawa Y, Manabe H, Yagami Y, Yamamoto H, Ito H, Kaizuka N, Nakahara Y, Sato T, Mitshufuji H, Yokoba M, Kubota M, Sasaki J, Naoki K.
Kasajima M, et al. Among authors: yagami y.
Oncology. 2023;101(1):69-76. doi: 10.1159/000526964. Epub 2022 Sep 14.
Oncology. 2023.
PMID: 36103811
Free PMC article.